Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applying multi-omics techniques to the discovery of biomarkers for acute aortic dissection. | Front Cardiovasc Med | 2022 | 36588568 | PubTator, text mining | PubMed |
| Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals. | Cell Death Discov | 2022 | 36581638 | PubTator, text mining | PubMed |
| Cytokine Pathways in Cardiac Dysfunction following Burn Injury and Changes in Genome Expression. | J Pers Med | 2022 | 36579591 | PubTator, text mining | PubMed |
| Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival. | Ther Adv Med Oncol | 2022 | 36579028 | PubTator, text mining | PubMed |
| Insights into the tumor microenvironment of B cell lymphoma. | J Exp Clin Cancer Res | 2022 | 36578079 | PubTator, text mining | PubMed |
| Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules. | Life (Basel) | 2022 | 36556382 | PubTator, text mining | PubMed |
| Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. | J Clin Med | 2022 | 36555876 | PubTator, text mining | PubMed |
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients. | Int J Mol Sci | 2022 | 36555612 | PubTator, text mining | PubMed |
| Host Cell Binding Mediated by Leptospira interrogans Adhesins. | Int J Mol Sci | 2022 | 36555188 | PubTator, text mining | PubMed |
| AP-2δ Is the Most Relevant Target of AP-2 Family-Focused Cancer Therapy and Affects Genome Organization. | Cells | 2022 | 36552887 | PubTator, text mining | PubMed |
| Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. | Biomedicines | 2022 | 36551790 | PubTator, text mining | PubMed |
| The Role of Cell-Free DNA in Cancer Treatment Decision Making. | Cancers (Basel) | 2022 | 36551600 | PubTator, text mining | PubMed |
| Single-cell transcriptomic, transcriptomic, and metabolomic characterization of human atherosclerosis. | Ann Transl Med | 2022 | 36544681 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease. | Acta Neuropathol Commun | 2022 | 36544231 | PubTator, text mining | PubMed |
| Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles. | Hum Genomics | 2022 | 36536459 | PubTator, text mining | PubMed |
Plasma proteomics reveals early, broad release of chemokine, cytokine, TNF, and interferon mediators following trauma with delayed increases in a subset of chemokines and cytokines in patients that remain critically ill. | Front Immunol | 2022 | 36532045 | PubTator, text mining | PubMed |
| EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. | Sci Adv | 2022 | 36525493 | PubTator, text mining | PubMed |
| Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. | Front Med (Lausanne) | 2022 | 36523779 | PubTator, text mining | PubMed |
| Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer. | Cell Biosci | 2022 | 36522745 | PubTator, text mining | PubMed |
| Re-evaluation of the myoepithelial cells roles in the breast cancer progression. | Cancer Cell Int | 2022 | 36510219 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=31